AVE-0657
- Generic Name
- AVE-0657
Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients
Phase 2
Terminated
- Conditions
- Heart FailureSleep Apnea SyndromesCheyne-Stokes Respiration
- Interventions
- Drug: placebo
- First Posted Date
- 2008-06-10
- Last Posted Date
- 2009-05-01
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 8
- Registration Number
- NCT00694720
- Locations
- 🇪🇸
Sanofi-Aventis Administrative Office, Barcelona, Spain
Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2009-07-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 38
- Registration Number
- NCT00614250
- Locations
- 🇪🇸
Sanofi-Aventis Administrative Office, Barcelona, Spain
🇫🇷Sanofi- Aventis Administrative Office, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath